Related references
Note: Only part of the references are listed.An observational study of oncology patients' utilization of breakthrough pain medication
Andrew N. Davies et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2008)
Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study
Carla Ripamonti et al.
SUPPORTIVE CARE IN CANCER (2007)
Incident pain and analgesic consumption decrease after samarium infusion: a pilot study
Carla Ripamonti et al.
SUPPORTIVE CARE IN CANCER (2007)
A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer
Russell K. Portenoy et al.
CLINICAL JOURNAL OF PAIN (2006)
Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine
Sebastiano Mercadante et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2006)
Opioids for the management of breakthrough (episodic) pain in cancer patients
G Zeppetela et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
Percutaneous vertebroplasty - A technique to treat refractory spinal pain in the setting of advanced metastatic cancer: A case series
AN Burton et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2005)
The pain pen for breakthrough cancer pain: A promising treatment
RH Enting et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2005)
Self-administered nitrous oxide for the management of incident pain in terminally ill patients: a blinded case series
JL Parlow et al.
PALLIATIVE MEDICINE (2005)
Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose
S Mercadante et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2004)
Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study
DB Carr et al.
PAIN (2004)
Optimization of opioid therapy for preventing incident pain associated with bone metastases
S Mercadante et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2004)
Pharmacotherapy of cancer-related episodic pain
G Zeppetella et al.
EXPERT OPINION ON PHARMACOTHERAPY (2003)
Cancer breakthrough pain characteristics and responses to treatment at a VA medical center
SS Hwang et al.
PAIN (2003)
Description and predictors of direct and indirect costs of pain reported by cancer patients
BV Fortner et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2003)
Breakthrough cancer pain:: Prevalence and characteristics in patients in Catalonia, Spain
X Gómez-Batiste et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2002)
A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids
RH Enting et al.
CANCER (2002)
Episodic (breakthrough) pain - Consensus conference of an expert working group of the European Association for Palliative Care
S Mercadante et al.
CANCER (2002)
A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain
BV Fortner et al.
JOURNAL OF PAIN (2002)
A new system for grading recommendations in evidence based guidelines
R Harbour et al.
BRITISH MEDICAL JOURNAL (2001)
Temporary sedation with midazolam for control of severe incident pain
MAB del Rosario et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2001)
Morphine and alternative opioids in cancer pain: the EAPC recommendations
GW Hanks et al.
BRITISH JOURNAL OF CANCER (2001)
Breakthrough cancer pain:: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulfate immediate release (MSIR®)
PH Coluzzi et al.
PAIN (2001)
The prevalence of episodic pain in cancer: a survey of hospice patients on admission
M Swanwick et al.
PALLIATIVE MEDICINE (2001)
Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice
G Zeppetella et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2000)